Simply in the previous years, researchers have realized the huge role that the microorganisms living inside and on us play in our health. The human microbiome, and specifically the gut microbiome, has actually been connected to multiple persistent illness, consisting of diabetes. An out of balance microbiome composition has actually been discovered in patients with diabetes, who tend to have a less diverse gut microbiome as compared to healthy people. Dimensions.
Some companies are developing diabetes treatments targeting the microbiome. The French Valviotis is currently conducting preclinical testing of a drug focused on increasing the microbiome diversity as a treatment for type 2 diabetes. Although appealing, the microbiome field is very young and its complexity makes it challenging to establish causation after finding correlation.
That world might not be so far away, as numerous companies are developing non-invasive techniques to replace finger pricking. Dimensions. Stability Applications has actually established a gadget called GlucoTrack that can determine glucose utilizing electro-magnetic waves and is currently available in Europe. Comparable technologies are turning up, with GlucoSense in London utilizing laser light to measure sugar levels and MediWise utilizing radio waves.
The GlucoWise sensor prototypePatches are likewise becoming a popular type of measuring blood glucose without needles, such as FreeStyle Libre, an inch-wide patch that can be used for approximately 2 weeks. At the University of Bath, researchers are establishing a graphene patch that could provide higher accuracy by determining sugar levels individually in multiple hair roots – Dimensions.
Meanwhile, Senseonic and Roche are working on a gadget that is implanted under the skin. Dimensions. Still, non-invasive options to determine blood sugar frequently face issues concerning accuracy. The famous glucose-measuring contact lens that Google announced in 2014 was dismissed as “technically infeasible” and even more developments will be required to reach the degree of precision of finger-pricking methods.
Researchers are currently speculating about microchips that can diagnose diabetes type 1 prior to the signs appear or nanorobots traveling in the blood stream while they determine glucose and provide insulin – Dimensions.”There’s little fiction left in this. I strongly think that microrobotics will come and will be part of our drug delivery within the next 10 years,” stated Tomas Landh, Director of Technique and Development Sourcing at Novo Nordisk, at the 2013 Medicon Valley Alliance Annual MeetingWhatever the future brings, it will undoubtedly make a big difference in the lives of millions of individuals worldwide.